Skip to content

Clinical trials

Phase 1/2 Neoplasm Metastasis trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 1/2 Country / region: Spain Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20092
20101
20111
20122
20132
20141
20165
20173
20192
20205
202110
202210
20235
20242
20253
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting22
Completed16
Terminated11
Active, not recruiting10
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
AstraZeneca3
Artios Pharma Ltd2
Ascendis Pharma Oncology Division A/S2
Eli Lilly and Company2
Hoffmann-La Roche2
Incyte Biosciences International Sàrl2
Incyte Corporation2
Ipsen2
Merck Sharp & Dohme LLC2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis62
Colorectal Neoplasms12
Carcinoma, Non-Small-Cell Lung11
Neoplasms10
Melanoma8
Breast Neoplasms7
Carcinoma, Renal Cell7
Endometrial Neoplasms7
Ovarian Neoplasms7
Triple Negative Breast Neoplasms7

Trials

Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.